Overall, Tan IIA has the potential to trigger apoptosis in pancreatic carcinoma by inhibiting the anti-apoptotic proteins of TCTP, Mcl-1, Bcl-xL and initiating the Caspase pathway’s activation. This evidence concerns the gene MCL1 and exocrine pancreatic carcinoma.